Work

Efficacy of Lenalidomide and Bortezomib for Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) Relapsing after Allogeneic Stem Cell Transplantation

Year: 2018

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2018-99-110559

Authors: Andrew M. Brunner, Traci M. Blonquist, Malgorzata McMasters, Gabriela S. Hobbs, Steven L McAfee, Jacalyn Rosenblatt, Philip C. Amrein, Christine Connolly, Aura Y. Ramos, Kaleb Mikami, Emma Logan, Bimalangshu R Dey, Thomas Spitzer, David E. Avigan, Yi-Bin Chen, Karen K. Ballen, Areej El-Jawahri, Amir T. Fathi

Institutions: Massachusetts General Hospital, Dana-Farber Cancer Institute, Beth Israel Deaconess Medical Center, Harvard University, University of Virginia Health System

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2907526428

Cites:

Cited by:

Related to: 10